Ph*rma G*ant To St*rt M*king *t-Home D*liveries Of N*sal Spr*y Flu V*ccine

AstraZeneca will start making at-home deliveries for FluMist, its nasal spray flu vaccine.

FluMist, on the market since 2003, was previously only available at pharmacies or doctors’ offices.

The pharmaceutical and biotechnology company received approval in the United States last year for self- or caregiver-administration at home.

ABC News did a